Norris Medicines Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 210607,
    "name": "Norris Medicines",
    "stock_name": "Norris Medicines",
    "full_name": "Norris Medicines Ltd",
    "name_url": "stocks-analysis/norris-medicines",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "14.50",
    "chg": 0.26,
    "chgp": "1.83%",
    "dir": 1,
    "prev_price": "14.24",
    "mcapval": "15.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524414,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE744C01029",
    "curr_date": "Apr 10",
    "curr_time": "",
    "bse_nse_vol": "2.65 k",
    "exc_status": "Active",
    "traded_date": "Apr 10, 2026",
    "traded_date_str": "2026 04 10",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/norris-medicines-210607-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Norris Medicines Ltd Falls to 52-Week Low of Rs 12 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3909902",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NorrisMedicines_priceRelatedfactors_3909902.png",
        "date": "2026-03-24 09:50:06",
        "description": "For the fourth consecutive session, Norris Medicines Ltd has closed lower, culminating in a fresh 52-week low of Rs 12 on 24 Mar 2026. This marks a 14.09% decline over the past four days, underscoring sustained selling pressure despite some pockets of strength in the broader market."
      },
      {
        "title": "Norris Medicines Ltd Falls to 52-Week Low of Rs 12.45 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-stock-falls-to-52-week-low-of-rs1245-3907569",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NorrisMedicines_priceRelatedfactors_3907569.png",
        "date": "2026-03-23 11:45:54",
        "description": ""
      },
      {
        "title": "Norris Medicines Ltd Reports Strong Quarterly Growth Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-reports-strong-quarterly-growth-amid-market-challenges-3843086",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NorrisMedicines_fintrenddot_3843086.png",
        "date": "2026-02-17 08:00:10",
        "description": "Norris Medicines Ltd has demonstrated a marked turnaround in its financial trajectory during the December 2025 quarter, posting robust revenue growth and record profitability metrics despite a challenging market environment. The company’s financial trend has shifted from flat to positive, signalling renewed operational momentum within the Trading & Distributors sector."
      },
      {
        "title": "Are Norris Medicines Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-norris-medicines-ltd-latest-results-good-or-bad-3840599",
        "imagepath": "",
        "date": "2026-02-14 19:58:26",
        "description": "Norris Medicines Ltd's latest financial results for Q2 FY26 present a complex picture. On one hand, the company reported net sales of ₹2.00 crores, reflecting a sequential growth of 36.99% from ₹1.46 crores in Q1 FY26 and a year-on-year increase of 57.48% from ₹1.27 crores in Q2 FY25. This topline growth suggests some market traction; however, it is overshadowed by significant operational challenges.\n\nThe net loss for the quarter was ₹0.72 crores, which marks a substantial deterioration compared to the previous quarter's loss of ₹0.31 crores. The operating margin fell to -24.50%, a sharp decline from -6.85% in Q1 FY26, indicating that the company's ability to manage costs relative to its sales has worsened considerably. This operational performance is concerning, as it highlights a widening gap between revenue growth and profitability, with the gross profit margin reported at a negative 30.00%.\n\nFurthermore..."
      },
      {
        "title": "When is the next results date for Norris Medicines Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-norris-medicines-ltd-3836095",
        "imagepath": "",
        "date": "2026-02-12 23:16:40",
        "description": "The next results date for Norris Medicines Ltd is scheduled for 14 February 2026...."
      },
      {
        "title": "Norris Medicines Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3800204",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NorrisMedicines_priceRelatedfactors_3800204.png",
        "date": "2026-01-22 11:16:24",
        "description": "Norris Medicines Ltd, a company operating in the Trading & Distributors sector, recorded a new 52-week low of Rs.12.5 today, marking a significant milestone in its ongoing price decline. This fresh low comes after a sustained period of underperformance relative to both its sector and the broader market indices."
      },
      {
        "title": "Norris Medicines Ltd Stock Falls to 52-Week Low of Rs.12.87",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-stock-falls-to-52-week-low-of-rs1287-3798479",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NorrisMedicines_priceRelatedfactors_3798479.png",
        "date": "2026-01-21 11:11:54",
        "description": "Norris Medicines Ltd’s shares declined sharply to a fresh 52-week low of Rs.12.87 on 21 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial and market performance."
      },
      {
        "title": "Norris Medicines Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3796717",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NorrisMedicines_priceRelatedfactors_3796717.png",
        "date": "2026-01-20 15:12:02",
        "description": "Norris Medicines Ltd touched a fresh 52-week low of Rs.13.5 today, marking a significant decline in its share price amid a sustained downward trend. The stock has underperformed both its sector and the broader market, reflecting ongoing pressures on the company’s financial and market metrics."
      }
    ],
    "total": 254,
    "sid": "210607",
    "stock_news_url": "https://www.marketsmojo.com/news/norris-medicines-210607"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2026",
      "details": "As per attachment.",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of The Board Meeting Held On 14Th February 2026 Pursuant To Regulation 30 And 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.",
      "datetime": "14-Feb-2026",
      "details": "As per attachment.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th February 2026 Pursuant To Regulation 30 And 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.",
      "datetime": "14-Feb-2026",
      "details": "As per attachment",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Norris Medicines Ltd Falls to 52-Week Low of Rs 12 as Sell-Off Deepens

2026-03-24 09:50:06

For the fourth consecutive session, Norris Medicines Ltd has closed lower, culminating in a fresh 52-week low of Rs 12 on 24 Mar 2026. This marks a 14.09% decline over the past four days, underscoring sustained selling pressure despite some pockets of strength in the broader market.

Read full news article

Norris Medicines Ltd Falls to 52-Week Low of Rs 12.45 as Sell-Off Deepens

2026-03-23 11:45:54

Read full news article

Norris Medicines Ltd Reports Strong Quarterly Growth Amid Market Challenges

2026-02-17 08:00:10

Norris Medicines Ltd has demonstrated a marked turnaround in its financial trajectory during the December 2025 quarter, posting robust revenue growth and record profitability metrics despite a challenging market environment. The company’s financial trend has shifted from flat to positive, signalling renewed operational momentum within the Trading & Distributors sector.

Read full news article

Are Norris Medicines Ltd latest results good or bad?

2026-02-14 19:58:26

Norris Medicines Ltd's latest financial results for Q2 FY26 present a complex picture. On one hand, the company reported net sales of ₹2.00 crores, reflecting a sequential growth of 36.99% from ₹1.46 crores in Q1 FY26 and a year-on-year increase of 57.48% from ₹1.27 crores in Q2 FY25. This topline growth suggests some market traction; however, it is overshadowed by significant operational challenges. The net loss for the quarter was ₹0.72 crores, which marks a substantial deterioration compared to the previous quarter's loss of ₹0.31 crores. The operating margin fell to -24.50%, a sharp decline from -6.85% in Q1 FY26, indicating that the company's ability to manage costs relative to its sales has worsened considerably. This operational performance is concerning, as it highlights a widening gap between revenue growth and profitability, with the gross profit margin reported at a negative 30.00%. Furthermore...

Read full news article

When is the next results date for Norris Medicines Ltd?

2026-02-12 23:16:40

The next results date for Norris Medicines Ltd is scheduled for 14 February 2026....

Read full news article

Norris Medicines Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-01-22 11:16:24

Norris Medicines Ltd, a company operating in the Trading & Distributors sector, recorded a new 52-week low of Rs.12.5 today, marking a significant milestone in its ongoing price decline. This fresh low comes after a sustained period of underperformance relative to both its sector and the broader market indices.

Read full news article

Norris Medicines Ltd Stock Falls to 52-Week Low of Rs.12.87

2026-01-21 11:11:54

Norris Medicines Ltd’s shares declined sharply to a fresh 52-week low of Rs.12.87 on 21 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial and market performance.

Read full news article

Norris Medicines Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-01-20 15:12:02

Norris Medicines Ltd touched a fresh 52-week low of Rs.13.5 today, marking a significant decline in its share price amid a sustained downward trend. The stock has underperformed both its sector and the broader market, reflecting ongoing pressures on the company’s financial and market metrics.

Read full news article

View All News